Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (351-360 of 421) with videos related to

Pageof 43
Sort By:
Haematologica|April 19, 2012
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A Douma, Melanie Tan, Roger E G Schutgens, et al.
BMJ Open|September 24, 2017
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2023
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant dataPhilippe Robin, Romain Le Pennec, Maggie Eddy, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2025
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trialNick van Es, Luuk J J Scheres, Kristen M Sanfilippo, et al.
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2021
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTEJeffrey I Weitz, Alfredo E Farjat, Walter Ageno, et al.
Annals of Internal Medicine|August 23, 2017
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient DataNick van Es, Grégoire Le Gal, Hans-Martin Otten, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
The Oncologist|May 12, 2023
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future DirectionTzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysisMaria A de Winter, Alicia Uijl, Harry R Büller, et al.
Pageof 43

Showing results (351-360 of 421) with videos related to

Sort By:
Pageof 43
Haematologica|April 19, 2012
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excludedRenée A Douma, Melanie Tan, Roger E G Schutgens, et al.
BMJ Open|September 24, 2017
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2023
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant dataPhilippe Robin, Romain Le Pennec, Maggie Eddy, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2025
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trialNick van Es, Luuk J J Scheres, Kristen M Sanfilippo, et al.
Blood|July 5, 2011
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapyInna Y Gong, Rommel G Tirona, Ute I Schwarz, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2021
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTEJeffrey I Weitz, Alfredo E Farjat, Walter Ageno, et al.
Annals of Internal Medicine|August 23, 2017
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis of Individual Patient DataNick van Es, Grégoire Le Gal, Hans-Martin Otten, et al.
Thrombosis Research|December 12, 2017
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort studyTony Wan, Marc Rodger, Wanzhen Zeng, et al.
The Oncologist|May 12, 2023
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future DirectionTzu-Fei Wang, Alok A Khorana, Giancarlo Agnelli, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysisMaria A de Winter, Alicia Uijl, Harry R Büller, et al.
Pageof 43